Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT
Eric Rohren, Elba Etchebehere, John C. Araujo, et al.
Journal of Nuclear Medicine (2015) Vol. 56, Iss. 10, pp. 1507-1512
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
Elba Etchebehere, John C. Araujo, Patricia S. Fox, et al.
Journal of Nuclear Medicine (2015) Vol. 56, Iss. 8, pp. 1177-1184
Open Access | Times Cited: 116
Deep learning for segmentation of 49 selected bones in CT scans: First step in automated PET/CT-based 3D quantification of skeletal metastases
Sarah Lindgren Belal, May Sadik, Reza Kaboteh, et al.
European Journal of Radiology (2019) Vol. 113, pp. 89-95
Open Access | Times Cited: 113
Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer
Ichiei Kuji, Tomohiko Yamane, Akira Seto, et al.
European Journal of Hybrid Imaging (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 86
Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
Christie Lin, Tyler Bradshaw, Timothy Perk, et al.
Journal of Nuclear Medicine (2016) Vol. 57, Iss. 12, pp. 1872-1879
Open Access | Times Cited: 66
Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients
Takuro Umeda, Mitsuru Koizumi, Shohei Fukai, et al.
Annals of Nuclear Medicine (2017) Vol. 32, Iss. 2, pp. 105-113
Open Access | Times Cited: 63
18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications
Peter Sang Uk Park, William Raynor, Yusha Sun, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6504-6504
Open Access | Times Cited: 48
Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone
Stephanie A. Harmon, Timothy Perk, Christie Lin, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 24, pp. 2829-2837
Open Access | Times Cited: 56
Automated classification of benign and malignant lesions in 18F-NaF PET/CT images using machine learning
Timothy Perk, Tyler Bradshaw, Song Chen, et al.
Physics in Medicine and Biology (2018) Vol. 63, Iss. 22, pp. 225019-225019
Closed Access | Times Cited: 51
Prostate-specific antigen flare induced by 223RaCl2 in patients with metastatic castration-resistant prostate cancer
Angelo Castello, Homer A. Macapinlac, Egesta Lopci, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2018) Vol. 45, Iss. 13, pp. 2256-2263
Closed Access | Times Cited: 44
18F-NaF PET/CT IMAGING IN FIBROUS DYSPLASIA OF BONE
Georgios Z. Papadakis, Georgios C. Manikis, Apostolos H. Karantanas, et al.
Journal of Bone and Mineral Research (2019) Vol. 34, Iss. 9, pp. 1619-1631
Open Access | Times Cited: 38
Therapy assessment of bone metastatic disease in the era of 223radium
Elba Etchebehere, Ana Emília Brito, Alireza Rezaee, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. S1, pp. 84-96
Closed Access | Times Cited: 33
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index
Sarah Lindgren Belal, Måns Larsson, Jorun Holm, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 5, pp. 1510-1520
Open Access | Times Cited: 9
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
Andrei Iagaru, Erik Mittra, Patrick M. Colletti, et al.
Journal of Nuclear Medicine (2016) Vol. 57, Iss. Supplement 3, pp. 19S-24S
Open Access | Times Cited: 29
Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT
Wouter van der Bruggen, Marlous Hagelstein-Rotman, Lioe‐Fee de Geus‐Oei, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 47, Iss. 6, pp. 1527-1537
Closed Access | Times Cited: 29
EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
Markus Linder, Elisabeth Glitzner, Sriram Srivatsa, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 11
Open Access | Times Cited: 28
Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
Kambiz Rahbar, Julia Konnert, Martin Bögemann, et al.
Nuklearmedizin - NuclearMedicine (2017) Vol. 56, Iss. 01, pp. 14-22
Closed Access | Times Cited: 28
68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients
Shiming Zang, Guoqiang Shao, Can Cui, et al.
Oncotarget (2017) Vol. 8, Iss. 7, pp. 12247-12258
Open Access | Times Cited: 27
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
Ana Emília Brito, Allan O. Santos, André Deeke Sasse, et al.
Oncotarget (2017) Vol. 8, Iss. 22, pp. 36001-36011
Open Access | Times Cited: 27
Multi-technique imaging of bone metastases: spotlight on PET-CT
Gurdip Azad, Gary Cook
Clinical Radiology (2016) Vol. 71, Iss. 7, pp. 620-631
Closed Access | Times Cited: 23
Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
Wouter van der Bruggen, Dennis Vriens, Maartje E. Meier, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 8, pp. e2980-e2994
Open Access | Times Cited: 18
Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of18F-Fluoride Metabolic Flux Than with Measurement of18F-Fluoride PET/CT SUV?
Gurdip Azad, Musib Siddique, Benjamin Taylor, et al.
Journal of Nuclear Medicine (2018) Vol. 60, Iss. 3, pp. 322-327
Open Access | Times Cited: 23
Evaluation of whole-body tumor burden with 68Ga-PSMA PET/CT in the biochemical recurrence of prostate cancer
Ana Emília Brito, Felipe Alves Mourato, R. P. M. de Oliveira, et al.
Annals of Nuclear Medicine (2019) Vol. 33, Iss. 5, pp. 344-350
Closed Access | Times Cited: 20
Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study
Takashi Oya, Yasutaka Ichikawa, Satsohi Nakamura, et al.
Annals of Nuclear Medicine (2023) Vol. 37, Iss. 6, pp. 360-370
Closed Access | Times Cited: 6
Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method
Paula Lapa, Margarida Marques, Gracinda Costa, et al.
Nuclear Medicine Communications (2017) Vol. 38, Iss. 4, pp. 325-332
Closed Access | Times Cited: 20
Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients
Arthur Letellier, Alison Johnson, N. How Kit, et al.
Molecular Imaging and Biology (2017) Vol. 20, Iss. 3, pp. 482-491
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top